Because the carrier mutation rate in the MUTYH gene, is about 1% of patients with low or mild polyposis and it has been found that heterozygous MUTYH mutation carriers can have an increased risk for developing CRC (especially in MAP patients aged >55 years), this can be a dilemma. This evidence concerns the gene MUTYH and polyposis.